跳至主要内容
临床试验/NCT03810677
NCT03810677已完成不适用

Treatment of Varicose Veins With the ELVeS® Radial® 2ring Slim Fiber. Are There Limitations?

be Medical2 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2019年4月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
150
试验地点
2
主要终点
Anatomic success

研究概览

简要总结

This study aims to prove that the ELVeS® Radial® 2ring slim fiber is safe and effective in endovenous laser ablation (EVLA) of varicose veins, with a reliable durability by evaluating procedural details/outcomes, clinical success, anatomic success, pain, post-operative adverse events and re-interventions.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient is at least 18 years old.
  • Patient must sign and date the informed consent form prior to treatment.
  • Presence of unilateral or bilateral primary symptomatic varicose veins (CEAP grade ≥ C2).
  • Patient has an insufficient Great Saphenous Vein (GSV), with or without laser ablation of anterior accessory saphenous vein (AASV), posterior accessory saphenous vein (PASV), and/or Small Saphenous Vein (SSV), with venous symptoms (valve incompetence), suitable for endovenous laser ablation (EVLA).
  • Maximum diameter of the to be treated veins is ≤ 14mm.

排除标准

  • Current deep vein thrombosis.
  • Acute superficial thrombosis.
  • Mean diameter of the to be treated veins > 14mm.
  • Tortuous or very superficial veins considered unsuitable for laser treatment.
  • Recurrent varicose veins.
  • Coagulopathy or bleeding disorders.
  • Contraindications to the use of general or regional anesthesia.

结局指标

主要结局

Anatomic success

时间窗: at 12 months follow-up

defined as occlusion of the treated veins and lack of reflux objectified with duplex ultrasonography

次要结局

  • Clinical success, defined as an objective improvement of clinical outcome after treatment, measured with the Venous Clinical Severity Score (VCSS)(at 12 months follow-up)
  • Post-operative adverse events(at 12 months follow-up)
  • Procedural characteristics(at index-procedure)
  • Pain scoring using the Visual Analog Scale (VAS)(at 1 week follow-up)
  • Re-interventions(at 12 months follow-up)

研究者

发起方
be Medical
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验